Menu
Our breath biomarker technology is a non-invasive method that analyzes the molecular compounds in exhaled breath. This technology holds the key to early disease detection, monitoring treatment efficacy, and even predicting health risks before they manifest clinically. It's a critical step towards personalized medicine, where treatments are tailored to individual patient profiles.
Indoor air quality significantly impacts health. Our VOC-enhanced IAQ sensors detect and analyze air quality in real-time, identifying potential health hazards. This technology is crucial in environments like hospitals and clinics, where maintaining optimal air quality can prevent the spread of infections and promote overall well-being.
By integrating the data from our breath biomarkers and IAQ sensors with AI-driven analysis, we're able to transform disease prediction and treatment. AI algorithms process this data to uncover patterns and indicators of health issues, enabling earlier and more accurate diagnoses.
This integrated approach also transforms prescription diagnosis. AI can analyze patient-specific data from our technologies to predict how individuals will respond to certain medications, reducing trial-and-error in prescriptions. Furthermore, monitoring post-drug results through breath biomarkers offers real-time insights into treatment effectiveness.
The data gathered through our technologies are invaluable in drug development. By providing a deeper understanding of disease mechanisms and patient responses, we can contribute to the development of more effective and targeted drugs, reducing time and costs in drug trials.